Fresenius Medical Care Showcases Clinical Research & Quality Improvement Initiatives at American Society of Nephrology 2016 Kidney Week Meeting

Len Usvyat, Vice President, Integrated Care Analytics

Fresenius Medical Care North America (FMCNA) had nearly 70 abstracts accepted by the American Society of Nephrology (ASN) for presentation at the 2016 Kidney Week Meeting and/or publication in the Abstract Supplement of the Journal of the American Society of Nephrology (JASN). These abstracts, authored by the company’s researchers, clinicians and caregivers, addressed a wide range of topics, including the impact social support can have on a patient’s laboratory goals.

Social Support May Improve Lab Results

Team members from FreseniusRx and FMCNA collaborated on an investigation that explored the link between social support and mineral bone disorder laboratory goals, and the abstract was published in JASN.[1]

For this analysis, the team pulled data from January 2014 through December 2015 on more than 185,000 FMCNA patients who completed a social work assessment questionnaire. This questionnaire gathered information on which sources of social support patients relied on. Comparisons were made between social support profiles versus the proportion of patients who met mean six-month lab goals for calcium, phosphate and intact parathyroid hormone (iPTH) levels.

The results identified that support from a spouse/partner, family member, health staff, community resource or church was potentially associated with better control of phosphate levels compared to support from a friend, neighbor or no one. The findings may suggest that close social support may be correlated to improved adherence to phosphate binders.

The study also found that the majority of patients with iPTH levels within goal received support from a spouse or partner. The study did reveal that almost all patients met their calcium laboratory targets and there were no remarkable differences among support types.

How FreseniusRx Supports Medication Adherence

Along with social support from a spouse, partner, family member or other resource, patients have access to support from FreseniusRx to help them manage their medications. There are many ways FreseniusRx may contribute to better lab outcomes through medication adherence, including:

  • Patients having 24/7 access to pharmacists who specialize in renal disease medications for questions about medication dosages, side effects, drug interactions, and more
  • Nephrologists and clinic staff being able to rely on FreseniusRx pharmacists for help interpreting how lab values relate to medications, including recommendations on adjustments to dosing, or alternate medications
  • Medication adherence programs providing patients with education and support. FreseniusRx has observed improved adherence from monthly phone calls to patients who sign up for available programs

Read more about the impressive breadth and depth of clinical research and quality improvement initiatives showcased by FMCNA at the ASN 2016 Kidney Week Meeting here.

[1] FN Speed, Y Jiao, JW Larkin, M Reviriego-Mendoza, D Maddux, J Demaline, S Roberts, TL Ketchersid, S Johnstone, LA Usvyat, FW Maddux: Impact of Social Support on Dialysis Patients Achieving Mineral Bone Disorder Laboratory Goals [PUB640]. J Am Soc Nephrol 27: 2016; p 1050A.